AlixLabs, the Lund-based semiconductor process startup developing Atomic Pitch Splitting (APS™), has completed its €15M Series A with a strategic top-up from Finnish investor Stephen Industries. The company is targeting beta testing with chipmakers in 2026 and manufacturing deployment by 2027. AlixLabs, a deep-tech semiconductor startup based in Lund, Sweden, has closed its €15 million […]
Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. Access is restricted to a trusted-access programme for vetted enterprise customers including Amgen, Moderna, and Thermo Fisher Scientific. OpenAI has launched GPT-Rosalind, a frontier reasoning model built specifically for life […]
The European Investment Bank is lending €20 million to BioLamina, the Swedish biotech that supplies the laminin-based cell culture matrices used by stem cell therapy developers worldwide. The funding will support expanded production of laminin technologies and animal-free drug safety testing methods. BioLamina, the Stockholm-based biotechnology company that produces the protein scaffolding used to grow […]
The Japan-headquartered EV battery manufacturer, controlled by China’s Envision Group and backed by Singapore’s sovereign wealth fund GIC, is mulling an IPO in Hong Kong that could raise up to $2 billion, Bloomberg reported on Thursday. The move marks a significant change from earlier plans to list in the US. Envision AESC, the electric vehicle […]
The Silicon Valley institution has closed roughly $7 billion for its expansion strategy fund, nearly doubling its comparable 2022 vehicle. Alfred Lin and Pat Grady, who took over as co-stewards in November 2025, are making the raise their opening statement on the AI era. Sequoia Capital has raised approximately $7 billion for a new fund, […]
In short: Anthropic has released Claude Opus 4.7, its most capable generally available model, with benchmark-leading scores on SWE-bench Pro (64.3% vs GPT-5.4’s 57.7%), multi-agent coordination for hours-long workflows, 3x higher image resolution, and a 14% improvement in multi-step agentic reasoning with a third of the tool errors. Priced at $5/$25 per million tokens, it […]
Slash, the vertical banking platform built by two college dropouts, has raised a $100M Series C backed by Khosla Ventures and Ribbit Capital. The company’s valuation has nearly quadrupled since its May 2025 Series B, the latest leg of a comeback story that began when its core market evaporated overnight. Slash, the San Francisco-based vertical […]
STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by existing investors including Pfizer Ventures and M Ventures. STORM Therapeutics, a Cambridge-based clinical-stage biotech targeting RNA modifications to treat cancer, has raised $56 million in […]
The Copenhagen fintech has built a platform of specialised AI agents that handle KYC and KYB work, document reviews, ownership mapping, risk rationale, in minutes rather than hours. NEA led the Series A; Northzone, Seedcamp, and PSV Tech participated. Spektr, a Copenhagen-based startup building AI infrastructure for financial compliance, has raised $20 million in a […]
